NCT00802789已完成不适用
Montelukast in Chronic Asthma: Non-interventional Study With Montelukast 10 mg
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 2,000
- 主要终点
- Documentation of asthma control via ACT (Asthma Control Test).
研究概览
简要总结
Treatment of patients insufficiently treated with ICS or ICS + LABA.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients Insufficiently Treated With ICS Or ICS + LABA.
排除标准
- 未提供
结局指标
主要结局
Documentation of asthma control via ACT (Asthma Control Test).
时间窗: 6 months (12 months optional)
次要结局
- Mini Asthma Quality of Life Questionnaire (Mini AQLQ).(6 months (12 months optional))
研究者
相似试验
Unknown
2 期
Montelukast With Status Asthmaticus, Ages 2-5AsthmaStatus AsthmaticusNCT00491790Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)52
撤回
3 期
A Study of Montelukast (MK-0476) Compared With Fluticasone in Pediatric Participants With Chronic Asthma (MK-0476-303)Asthma, BronchialNCT00540839Organon and Co
已完成
4 期
Role of Montelukast in Asthma and Allergic Rhinitis PatientsAsthma and Allergic RhinitisNCT03380975Clinision600
进行中（未招募）
1 期
Montelukast as a controller of atopic syndrome - MONTAS-study - MONTASAllergic symptoms (rhinitis, conjunctivits, asthma, oral symptoms and atopic eczema) caused by pollen allergy to birch or timothy.MedDRA version: 20.0Level: LLTClassification code 10001709Term: Allergic conjunctivitisSystem Organ Class: 100000004853MedDRA version: 20.0Level: LLTClassification code 10003641Term: Atopic eczemaSystem Organ Class: 100000004858MedDRA version: 20.0Level: LLTClassification code 10001723Term: Allergic rhinitisSystem Organ Class: 100000004855MedDRA version: 20.0Level: LLTClassification code 10001705Term: Allergic asthmaSystem Organ Class: 100000004855EUCTR2007-000047-99-FITari Haahtela50
尚未招募
早期 1 期
Impact Of Montelukast On Allergic Rhinitis And Its Inflammatory MakersAllergic RhinitisNCT05381207Assiut University60